News

April 23, 2014 — Xeltis announced it finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural,...

Cytori Stem Cell Therapy Heart Failure Treatments PRECISE Trial

Cytori Therapeutics announced publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic ischemic heart failure. 

April 18, 2014 — New research presented at the 34th annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) demonstrated the CorMatrix particulate extracellular...

Cardiac Stem Cells Regeneration Therapy

Generating new cardiac muscle from human embryonic stem cells (hESCs) and/or induced pluripotent stem cells (...

Cardiac stem cells regeneration therapy clinical trial study

Marty Greenfield lives with crushing pain every day due to angina. He has suffered a heart attack, and a coronary bypass procedure and angioplasty have provided little relief. His doctor referred...

Stem Cell Therapy Gene Cardiac Regeneration

After a heart attack, there is often permanent damage to a portion of the heart. This happens, in part, because cardiac muscle cells are terminally differentiated and cannot proliferate after...

Ademedus CardioCel Stem Cell Therapy

The U.S. Food and Drug Administration (FDA) cleared Admedus’s CardioCel, a tissue product to repair and treat a range of cardiovascular and vascular defects. The company is looking to complement...

Scientists at Icahn School of Medicine at Mount Sinai may have developed a tissue model for the human heart that can bridge the gap between animal models and human clinical trial patients. Mount...

BioLeonhardt Implantable Stem Cell Pump Cath Lab Therapies Heart Failure

BioLeonhardt, a Leonhardt Ventures company based in Los Angeles, unveiled its implantable stem cell pump at the 9th Annual Cell Therapy for Cardiovascular Disease meeting at Columbia University,...

CorMatrix Cardiovascular Extracellular Matrix ECM Bioscaffold

CorMatrix Cardiovascular Inc. received a patent for an augmented injectable extracellular matrix (ECM) bioscaffold. 

Icahn Mount Sinai HDL LDL Nanotherapy Stem Cell Therapies Cath Lab

An international research team, led by Icahn School of Medicine at Mount Sinai investigators, designed and tested a high-density lipoprotein (HDL) nanoparticle loaded with a statin drug. In mouse...

July 15, 2013 — Leonhardt Ventures and Core Manufacturing LLC have announced a new partnership to manufacture and bring to market a lineup of medical technologies.

Cardiobridge, VAD, heart pump, hemodynamic support

The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering innovative new approaches to address heart and cardiovascular disease.

January 31, 2013 — Belgian biotechnology company Cardio3 BioSciences (C3BS) announced it has received authorization to begin its Congestive Heart failure Cardiopoietic Regenerative Therapy (CHART-...

2012 Top 10 Advances in Heart Disease and Stroke Research

Resuscitation, cell regeneration, a new high blood pressure treatment and developments in devices for treating stroke are among the key scientific findings that make up this year's top...

Cardiac Stem Cells Regeneration Therapy Structural Heart

Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat serious heart problems in children, have conducted the first direct comparison of the...

June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million grant from The Starr...

June 1, 2012 — LoneStar Heart Inc. announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts into functioning heart muscle cells to treat damage...

A late-breaking stem cell trial presented at the American College of Cardiology (ACC) Annual Scientific Session showed only minor improvement in heart pumping capability between baseline and...

March 19, 2012 – Individuals suffering from chronic heart failure (CHF) can look forward to the appearance of many new drug options over the next few years and place hope in a cure through future...

March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells...

January 26, 2012 — Amorcyte LLC, a NeoStem company, announced the enrollment of the first patient in the Amorcyte PreSERVE Phase II trial for acute myocardial infarction. The study is a...

January 13, 2012 — Amorcyte Inc., a NeoStem Inc. company, announced the expansion of intellectual property protection around its lead product candidate, AMR-001, with the grant of U.S. patent...

December 20, 2011 – After a heart attack, the portions of the heart damaged by a lack of oxygen become scar tissue. Researchers have long sought ways to avoid this scarring, which can harden the...

December 20, 2011 –– Howie Lindeman was facing the loss of his career and Neim Malo wasn’t supposed to see 2011. They were each treated for heart disease years ago using their own stem cells to...

December 5, 2011 – University Hospitals Case Medical Center researchers could still be close to giving heart attack patients a second chance…just not as they originally thought.

 

November 18, 2011 – CorMatrix Cardiovascular Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the company full investigational device exemption (IDE)...

November 16, 2011 — Heart failure patients with a previous myocardial infarction showed an average of 12 percent improvement one year following an investigative treatment that infused them with...

October 24, 2011 — NeoStem Inc. and Amorcyte Inc announced the closing of their previously publicized merger transaction following approval by the shareholders of both companies on Oct. 14, 2011....

September 27, 2011 — A team of physicians, engineers and materials scientists at Children's Hospital Boston and the Massachusetts Institute of Technology (MIT) have created cardiac patches, with...

September 14, 2011 — The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a $12.8 million program project grant to Roberto Bolli, M.D., for...

September 6, 2011 — Mesoblast Ltd. announced it received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 European clinical trial for Revascor, its...

August 25, 2011 – ­ The Munich biotech company apceth started its first Phase I/II clinical study on somatic cell therapy for advanced peripheral arterial occlusive disease (pAOD...

 August 19, 2011 — NeoStem Inc., an international biopharmaceutical company, reported progress toward commencement of a Phase II clinical trial for AMR-001 for the treatment of acute...

May 11, 2011 – Terumo entered into a purchase agreement to acquire Harvest Technologies Corp, which is working to commercialize the world's first point-of-care stem cell therapy.

April 22, 2011 – The first patient has been treated in a European multicenter CIRCUS trial. The study is looking at NeuroVive Pharmaceutical’s CicloMulsion cremophor-free IV cyclosporine...

April 4, 2011 – The U.S. Food and Drug Administration (FDA) has approved a 210-patient investigation devices exemption (IDE) clinical trial to test the efficacy of a bone marrow stem cell...

March 22, 2011 – The U.S. Food and Drug Administration (FDA) has approved a 210-patient investigation devices exemption (IDE) clinical trial to test the efficacy of a bone marrow stem cell...

March 21, 2011 - Researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue and improved function to injured heart areas,...

February 1, 2011 – The U.S. Food and Drug Administration has approved a Phase I clinical trial to test a new technology for treating critical limb ischemia (CLI). The Investigational Device...

December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific...

November 24, 2010 – Researchers at Northwestern are utilizing a patient’s own stem cells to regenerate heart and vascular tissue, offering a potential new treatment for cardiovascular disease....

September 24, 2010 - The U.S. Food and Drug Administration (FDA) has granted conditional approval to start a trial testing a new treatment to reduce the incidence of new onset postoperative atrial...

September 2, 2010 - The STAR-heart study, which was presented at the European Society of Cardiology 2010 Congress in August 2010, reported that the intracoronary injection of autologous stem cells...

Heart failure is a progressively debilitating disease that dramatically decreases the life expectancy and quality of life of affected patients. Nearly 5.8 million Americans are diagnosed with...

July 16, 2010 – A new extracellular matrix (ECM) biomaterial device recently received a CE mark, meaning it can now be marketed in European Union countries. The CorMatrix ECM for Cardiac Tissue...

July 14, 2010 – A Belgian biotechnology company recently announced positive safety data and preliminary efficacy results from a clinical trial of its new stem cell therapy for heart failure.

January 4, 2010 – The FDA's permission is sought to allow a safety and feasibility trial for the PHOENIX System, which allows tissue stimulation and injections of biologic or pharmacologic agents...

December 16, 2009 – Patient enrollment was recently completed for a study evaluating the ability of cardiopoietic cells to restore cardiac function in heart failure patients.

November 13, 2009 – A 48-patient IDE clinical trial conducted at seven sites in the U.S. and one site in India using the Harvest Technologies’ Bone Marrow Aspiration Concentrate (BMAC) System to...

October 16, 2009 – The Clinical Center of Serbia, Institute for Cardiovascular Diseases today said it treated its first patient with a revolutionary cell-based therapy for heart failure.

October 13, 2009 – By mimicking the way embryonic stem cells develop into heart muscle in a lab, Duke University bioengineers believe they have taken an important first step toward growing a...

July 31, 2009 – Theregen Inc. said its Anginera heart patch, a living three-dimensional engineered human tissue, was used as the foundation for the ”living band-aid for the heart,” as reported...

July 28, 2009 – Bioheart Inc. today said the FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure.

July 24, 2009 – Michael Jones has become the world’s first recipient of adult cardiac stem cells to treat congestive heart failure. Jones’ infusion on July 17 marks the world’s first phase-one,...

July 24, 2009 – Injured heart tissue normally can't regrow, but researchers at Children's Hospital Boston have now laid the groundwork for regenerating heart tissue after a heart attack without...

July 8, 2009 – Bioheart Inc. said this week a panel discussion on myoblast (muscle stem cell) therapy between distinguished physicians gave the technology a big endorsement.

July 8, 2009 - Pluristem Therapeutics Inc. said yesterday its first patient enrolled in a phase I clinical trial that will evaluate the safety of the company’s allogeneic, placental-derived,...

July 8, 2009 - Marc Gerdisch, M.D., director of cardiothoracic surgery at the St. Francis Heart Center and a partner at Cardiac Surgery Associates, is using the CorMatrix Extracellular Matrix (ECM...

June 30, 2009 - Doctors at the Cedars-Sinai Heart Institute said today they completed the first procedure in which a patient's own heart tissue was used to grow specialized heart stem cells that...

June 25, 2009 – Six-month follow-up results were released this week for a patient treated with adult stem cells in a clinical study of idiopathic dilated cardiomyopathy, which showed major...

May 29, 2009 - Celladon Corp. this week presented phase 1 data from the Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID), a first-in-human phase 1/2...

May 27, 2009 - Cytori completed enrollment in the first study to investigate adipose derived stem and regenerative cells in chronic heart disease.

May 22, 2009 – Biotronik said today it is partnering with Belgian biotechnology company Cardio3 BioSciences in its C-Cure stem cell clinical trial, where it will provide implantable cardioverter...

May 19, 2009 - Pervasis Therapeutics Inc. today announced new preclinical data for its minimally invasive cell therapy, PVS-10200, which is used following an intervention for peripheral arterial...

April 14, 2009 – Regenerx Biopharmaceuticals Inc. said yesterday researchers at the University of Texas Southwestern Medical Center (UTSW) in Dallas, TX, published a new paper elaborating on the...

April 14, 2009 - Three research centers have been awarded funding from the American Heart Association, with support from the Jon Holden DeHaan Foundation, to study the development and mechanisms...

April 2, 2009 - TCA Cellular Therapy’s Medical Director Gabriel Lasala, M.D. presented preliminary results of an adult stem cell treatment for severe limb ischemia Sunday at the American College...

April 1, 2009 - On March 30, the Heart Hospital of Austin, TX became the first hospital in the world to treat a patient enrolled in a groundbreaking Phase II study designed to test the...

March 9, 2009 - Cytori Therapeutics Inc. completed enrollment in its APOLLO trial to evaluate the safety and feasibility of adipose tissue-derived stem and regenerative cells, processed with the...

February 12, 2009 - Osiris Therapeutics Inc. yesterday announced final two-year results for the company's trial evaluating Prochymal — a proprietary formulation of adult stem cells — for the...

January 28, 2009 - Attended by over 40 cardiothoracic surgeons, Cardiogenesis Corp.'s education symposium at the recent Society of Thoracic Surgeons Meeting in San Francisco was entitled "...

January 5, 2009 - The University of California, San Diego Medical Center is the first hospital in California to enroll patients in a multi-center clinical trial, sponsored by Angioblast Systems...

November 10, 2008 - The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) is a three-day program dedicated to cell-based therapies for cardiovascular repair and...